FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
-15.62%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$27.6M
AUM Growth
+$27.6M
(-16%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $12.4M | 45.08% | 133,691 | – | – |
|
2
Natera
NTRA
$23.1B
| $5.64M | 20.46% | 159,160 | – | – |
|
|
CBAY
3
DELISTED
Cymabay Therapeutics
CBAY
| $4.84M | 17.57% | 1,641,804 | – | – |
|
|
VRNA
4
Verona Pharma
VRNA
$9.16B
| $4.66M | 16.89% | 1,111,112 | – | – |
|